RSR Explains Extraordinary Cancer Antibody Treatment
This is the show from Friday, April 22nd, 2016
SUMMARY:
CBS News has reported on a new cancer treatment tried on 35 terminally-ill, advanced-stage leukemia sufferers. The disease went into remission in 94%, (33 of 35) patients! Dr. Michael Grossbard, New York University's Perlmutter Cancer Center leukemia specialist told CBS News, "Oncologists are reluctant to use the word extraordinary. But these [results] are extraordinary. These are really remarkable findings..." Real Science Radio host Bob Enyart turns to RSR's targeted-antibody expert, Jonathan Bartlett, who explains both the molecular biology behind this new treatment and the worldview implications ahead of it. Bartlett also discusses the impossibility that an evolutionist faces in trying to understand such a treatment and why so many scholars are fleeing Darwinism.
Hear Jonathan's 2012 RSR intereview by visiting the Blyth Institute at www.blythinstitute.org and you can check out the Alternatives to Methodological Naturalism Conference at www.am-nat.org.
This is the show from Friday, April 22nd, 2016
SUMMARY:
CBS News has reported on a new cancer treatment tried on 35 terminally-ill, advanced-stage leukemia sufferers. The disease went into remission in 94%, (33 of 35) patients! Dr. Michael Grossbard, New York University's Perlmutter Cancer Center leukemia specialist told CBS News, "Oncologists are reluctant to use the word extraordinary. But these [results] are extraordinary. These are really remarkable findings..." Real Science Radio host Bob Enyart turns to RSR's targeted-antibody expert, Jonathan Bartlett, who explains both the molecular biology behind this new treatment and the worldview implications ahead of it. Bartlett also discusses the impossibility that an evolutionist faces in trying to understand such a treatment and why so many scholars are fleeing Darwinism.
Hear Jonathan's 2012 RSR intereview by visiting the Blyth Institute at www.blythinstitute.org and you can check out the Alternatives to Methodological Naturalism Conference at www.am-nat.org.
Last edited by a moderator: